Navigation Links
Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
Date:3/18/2008

New Rochelle, NY, March 18, 2008Biotechnology companies are increasingly turning to developing nations as sites for clinical trials, reports Genetic Engineering and Biotechnology News (GEN). Increasing competition for clinical trial patients in the industrialized world is one of the major reasons for the offshore move, according to an article in the March 15 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2401)

A ready supply of patients and large potential markets are other key drivers for the decision to conduct clinical trials in developing countries, notes John Sterling, Editor-in-Chief of GEN.

Developing nations also offer less competition from other ongoing clinical trials and patients and investigators are often eager to participate. In addition, biotech and pharma companies usually conduct trials in cities, as opposed to rural areas, since many developing world cities have doctors, staff, and equipment similar to conditions that are found in the West.

Nevertheless, there are cultural issues that must be addressed in some developing nations. For example, companies need to ascertain that the disease to be studied in a trial is actually recognized as a local morbidity. In many countries, mental illness, insomnia, and depression are seen as character weaknesses rather than as illnesses.

In the GEN article, insights on conducting clinical trials in developing countries are provided by Peregrine Pharmaceuticals, Integrated Clinical Trials Services, PharmaNet, Advaxis, and Pharm-Olam International.


'/>"/>

Contact: John Sterling
jsterling@genengnews.com
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

0

GOOD

Page: 1

Related biology technology :

1. Interleukin Genetics Retains Top Life Science Communications Firms
2. On the trail of rogue genetically modified pathogens
3. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
4. deCODE Genetics Announces Full-year 2007 Financial Results
5. Genetic manipulation might model cystic fibrosis
6. NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss
7. AssureRx Closes Round of Funding to Commercialize Pharmacogenetic Test
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. Genetic Engineering & Biotechnology News reports on advances in miRNA
10. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
11. Honey bee invaders exploit the genetic resources of their predecessors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., NEW YORK, Nov. 30 Th...ch (MJFF) today announced $1.5 million in total aw...ntially disease-modifying therapies for Parkinson,...l Approaches to Drug Discovery for Parkinson,s Dis...Corporation, plc (NYSE: ELN ), a neuroscience-ba...
(Date:11/30/2009)..., AMSTERDAM, November 30 Biop...y that the first patients have been enrolled in it...TIR(TM). The study is,designed to show reduction i...r following an allogeneic stem cell transplantatio...od cancer patients eligible for an allogeneic,stem...
(Date:11/30/2009)..., ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ ...it has completed enrollment in the Phase II clinic.../2009 recommended strains) VLP vaccine candidate i...dults). This randomized, double-blind, active-con...y and immunogenicity of two different doses (15 mc...
(Date:11/30/2009)... , SEATTLE, Nov. 30 ...IC) announced today that its new class of platinum..., demonstrated a stronger anti-tumor potency and a...ased compounds as well as the ability to overcome ...sults were presented in a paper titled "Novel Bis-...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
... high-throughput screening of HSV , , Cindy ...elanie Palmer Dwight DuBois ,Stratagene , Str...etection,module, * , , ff ,a single-tube ...) DNA. Because,it is performed in a closed-tube ...ation, HSV detection is simplified, and the risk o...
...n PCR system, developed for,highfidelity PCR ,...Bai * Daniel McMullan,* Barbara McGowan * Holly ..., Stratagene announces the addition of the TaqPlus... PCR products. The TaqPlus Precision PCR system,... polymerases and a reaction,buffer that has been...
...w plasmid library construction,kits , , ...Neiditch Alan Greener John C. Bauer Mike Kobrin... II,pcmv-script and pAD-GAL4-2.1 XR library co...As and high-efficiency transformation into Epicuri...,Plasmid cDNA libraries constructed with XL10-Go...
Other Biology Technology:HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 2HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 3HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 4High-Fidelity PCR with a Novel Polymerase Mixture 2High-Fidelity PCR with a Novel Polymerase Mixture 3High-Fidelity PCR with a Novel Polymerase Mixture 4High-Fidelity PCR with a Novel Polymerase Mixture 5High-Fidelity PCR with a Novel Polymerase Mixture 6High-Fidelity PCR with a Novel Polymerase Mixture 7High-Fidelity PCR with a Novel Polymerase Mixture 8High-Fidelity PCR with a Novel Polymerase Mixture 9High-Fidelity PCR with a Novel Polymerase Mixture 10High-Fidelity PCR with a Novel Polymerase Mixture 11Generate High-Quality, Directional Plasmid cDNA Libraries 2Generate High-Quality, Directional Plasmid cDNA Libraries 3Generate High-Quality, Directional Plasmid cDNA Libraries 4Generate High-Quality, Directional Plasmid cDNA Libraries 5Generate High-Quality, Directional Plasmid cDNA Libraries 6Generate High-Quality, Directional Plasmid cDNA Libraries 7
(Date:11/30/2009)...A new scientific organisation is needed to monitor...ountries at Copenhagen to cut their deforestation ...Leeds. , Existing government agencies and resear...sands of satellite images of the Earth,s surface c..., Now, a paper published by Dr Alan Grainger in ...
(Date:11/30/2009)..., CLEMSON Clemson University researchers Ron Falt...ronmental Protection Agency grant to study the saf...ns located deep below the earth,s surface. , Wit...ls believed to be the leading cause of global warm...t promising alternatives for reducing emissions us...
(Date:11/30/2009)... This release is available in German . , Th...laborative Research Centres as of 1 January 2010. ...ants Committee in Bonn. The new centres will initi...million. In addition, 20 percent overhead funding ...project. The centres, research topics range from m...
Breaking Biology News(10 mins):World forest observatory needed to monitor vital role of forests in climate deal 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9African Americans with colorectal cancer have poorer outcomes lower survival rates 61245 1African Americans with colorectal cancer have poorer outcomes lower survival rates 61245 2Underground mine ventilation subject of study 61242 1Underground mine ventilation subject of study 61242 2Springer launches new journal Food Digestion 10708 1Springer launches new journal Food Digestion 10708 2
...Stevens Institute of Technology Professor Xiaojun ...nal Research Award in Biomedical Engineering from ... support his research titled, Novel structured nan...nt Professor in the Department of Chemical, Biomed... School of Engineering and Science, is focusing hi...
...-- The National Institutes of Health has selected ...TMB) Assistant Professor of Neurology Pedro Fernan... Directors New Innovator Award. , NIH Director Dr...ecipients of the grants, designed to foster young ...ymposium at NIH headquarters Wednesday, Sept. 19. ...
...itute of Biological Sciences (AIBS), in conjunctio... will host the fourth annual symposium on evolutio...in Atlanta, Georgia. The symposium, titled Evoluti...is part of the 2007 Professional Development Confe...logy Teachers. , The aim of the symposium is to...
Other Biology News:NIH awards researcher $1.5 million 'new innovator' grant for fruit-fly studies of prion proteins 2NIH awards researcher $1.5 million 'new innovator' grant for fruit-fly studies of prion proteins 3AIBS to cohost symposium on evolution, disease and human health 2AIBS to cohost symposium on evolution, disease and human health 3AIBS to cohost symposium on evolution, disease and human health 4
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
Anti-Acid Phosphatase, Potato Polyclonal Antibody, Unconjugated from CHEMICON
Anti-Latanoprost (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
Anti-Human C3a / C3a des-Arg (neo-epitope) Monoclonal Antibody, Unconjugated, Clone 2991 from Cell Sciences
Biology Products: